secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001193125-24-278688
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics board members Altman and Poukalov resign; board rebalanced
----------------------------------------------------------------------------

- Michael Altman and Konstantin Poukalov resigned from Lyra Therapeutics Board effective December 12, 2024.
- Maria Palasis, Ph.D. moved from Class III to Class I director to rebalance board classes; term extended to 2027.
- Board now consists of two Class I, two Class II, and two Class III directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524278688/0001193125-24-278688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524278688/d888261d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-278688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer